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ABSTRAK
Tujuan: mengevaluasi profil respons imun pasien talasemia mayor di Indonesia yang menjalani splenektomi 
dan tanpa splenektomi. Metode: penelitian dilakukan di Pusat Thalassaemia, Rumah Sakit Cipto Mangunkusumo 
Jakarta pada bulan September 2013 – Februari 2014. Metode belah lintang komparatif dilakukan pada pasien 
talasemia mayor sehat berusia >12 tahun dan HIV negatif. Kelompok non-splenektomi terbentuk setelah 
melakukan matching usia dan jenis kelamin pada kelompok pasca-splenektomi. Analisis terdiri dari respons 
imun non-spesifik (jumlah dan fagositosis neutrofil) dan respons imun spesifik (jumlah dan fungsi imunitas 
selular). Episode infeksi dianalisis sebagai parameter respons imun in vivo. Hasil: kelompok pasca-splenektomi 
mempunyai jumlah neutrofil  lebih tinggi dan fagositosis neutrofil lebih rendah dibanding non-splenektomi. 
Kelompok pasca-splenektomi mempunyai jumlah limfosit total, jumlah limfosit T, jumlah limfosit T CD4+ 
dan CD8+ yang lebih tinggi dibanding non-splenektomi (p<0,05). Rasio CD4+/CD8+ sama antara kedua 
kelompok. Tidak ada perbedaan respons imun spesifik kualitatif (fungsi limfosit T CD4+ dan CD8+) antara 
kedua kelompok. Median infeksi ringan kelompok pasca-splenektomi adalah 2,02 (kisaran 0 sampai 12) kali 
dan kelompok non-splenektomi adalah 0,81 (kisaran 0 sampai 8) kali (p=0,004). Infeksi berat kelompok pasca-
splenektomi adalah sepsis selama 2 minggu dan diare selama 1 minggu. Sedangkan infeksi berat kelompok 
non-splenektomi adalah demam tifoid selama 4 hari. Kesimpulan: terdapat perbedaan bermakna respons imun 
diantara pasien talasemia mayor. Kelompok pasca-splenektomi menunjukkan kerentanan terhadap infeksi lebih 
besar dibanding non-splenektomi.
Kata kunci: respons imun, talasemia mayor, splenektomi.
ABSTRACT
Aim: to describe non-spesific and specific immune response profile in Indonesian thalassemia major with and 
without splenectomy. Methods: this study was held at Thalassaemia Centre, Cipto Mangunkusumo Hospital Jakarta 
on September 2013 – February 2014. A comparative cross sectional study was conducted in healthy, thalassemia 
major aged more than 12 year and seronegative HIV. They were matched in age and sex for splenectomised and 
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INTRODUCTION
Most of the thalassemia patient’s morbidity 
and mortality are caused by heart failure or 
infection.1-3 In Italy, infection was the second 
cause of death after heart failure whereas in 
Thailand, infection was the most common cause of 
morbidity and mortality.4,5 In Thalassaemia Center, 
Cipto Mangunkusumo Hospital, Jakarta, infection 
(34%) was the second mortality cause after heart 
failure (46%).6 Moreover, post-splenectomy 
infection has higher mortality and morbidity.7 A 
review of Bisharat7 showed that 3.2% of 19,680 
splenectomy patients had invasive infection with 
mortality rate 1.4%. Whereas, an observation 
at Thalassaemia Centre, Cipto Mangunkusumo 
Hospital in 2011 found that number of invasive 
infection among post-splenectomy patient was 
higher than non-splenectomy patient (p<0.001). 
However, there was no significant difference 
between type of thalassemia and number of 
infection (p>0.05). The severe infections were 
pneumonia, sepsis, liver abscess and tuberculosis.6 
In addition, pneumonia was one of the important 
causes of infection following splenectomy in 
thalassemia major patients.8,9
The mechanisms underlying this increased 
susceptibility to infections in thalassemia 
are abnormal immune response due to 
either pathophysiology of the disease, blood 
transfusion, iron overload, splenectomy or zinc 
deficiency.2,4,10,11 Several studies also showed that 
abnormal immune response was associated with 
chelation therapy.12-14
The results of immune response study 
among thalassemia patients varied. Research of 
innate immunity on thalassemia patients showed 
disturbance of macrophage phagocytes function2,4 
whilst Shaiegan et al.15 and Pattanapanyasat et 
al.16 revealed no differences on neutrophil 
phagocytosis between thalassemia patients 
and normal person. Furthermore, a research on 
cellular imunity on thalassemia patients showed 
increased amount and activity of suppressor 
cell CD8+, decreased ratio of CD4+/CD8+, 
decreased of T lymphocyte proliferation and 
increase T lymphocyte activation2,4 whereas 
humoral immunity research showed similar result 
between thalassemia and normal person.17-19 A 
research conducted by Vergin et al.19 showed 
no difference on immunoglobin level between 
b-thalassemia post-splenectomy and non-
splenectomy. Until now, non-spesific and specific 
immune response in thalassemia in Indonesia are 
still unknown. Therefore, the aim of this study 
is to describe non-spesific and spesific immune 
response between post-splenectomy and non-
splenectomy thalassemia patients. Furthermore, 
it is important for internist to know about this 
study since most of the splenectomy patients in 
Indonesia were already at adult stage.
METHODS
Patients
A comparative cross sectional study was held 
at Thalassaemia Centre, Cipto Mangunkusumo 
non-splenectomised groups, analysing the non-spesific immune response (neutrophil count and phagocytosis) 
and specific immune response (count and function of cellular immunity). Infection episodes were also analized as 
immune response in vivo parameter. Results: splenectomised thalassemia major showed increased neutrophil count 
but significantly decreased non-spesific immune response (neutrophil phagocytosis). Spesific immune response of 
splenectomised group presented significantly higher absolute lymphocyte, lymphocyte T, CD4+ and CD8+ counts 
compared to non-splenectomised thalassemia major (p<0.05). Ratio CD4+/CD8+ were similar in these groups. 
Serum marker of activated cellular imunity function (IL-2 and TNF-α) were similar among two groups. Mild 
infection episodes on splenectomised and non-splenectomised group were 2.02 (ranged 0 to 12) times and 0.81 
(ranged 0 to 8) times (p=0.004), respectively. Severe infection on splenectomised group were sepsis for 2 weeks 
and diarrhea for 1 week, whereas on non-splenectomised group was typhoid fever for 4 days. Conclusion: there 
were significant differences on immune response among thalassemia major patients. Splenectomised thalassemia 
major showed a greater degree of susceptibility to infections than non-splenectomised thalassemia major.
Key words: immune response, thalassemia major, splenectomy.
Vol 46 • Number 3 • July 2014                                  Immune response of thalassemia major patients in Indonesia
219
Hospital Jakarta on September 2013 – February 
2014. This present study enrolled 116 healthy 
thalassemia major patients, aged 12 years or 
older (median age 21 years; ranged 12 to 38 
years). Patients were excluded from this study 
if they had HIV positive. Blood was taken just 
before a scheduled transfusion. The protocol for 
the present study was approved by the Ethics 
Committee of Faculty of Medicine Universitas 
Indonesia, Jakarta, Indonesia. Informed consent 
was obtained from all subjects before participated 
in this study.
Clinical Laboratory Parameters
Clinical laboratory examinations included 
hemoglobin, hematocrit, differential leukocyte 
count and peripheral blood morphology was 
carried out. Blood smear were performed in order 
to rule out the nucleated RBCs. Levels of serum 
ferritin and serum transferrin saturation were also 
determined. Serum transferrin saturations were 
calculated according to ratio serum iron to total 
iron binding capacity (TIBC) multiplied by 100.
Thalassemia Major Immune Response
This study evaluated non-spesific and 
spesific immune response. Non-spesific immune 
response consisted of neutrophil count and 
phagocytosis. The quantitative specific immune 
response evaluated the lymphocyte count, the 
subsets CD4+ and CD8+ T lymphocyte and ratio 
CD4+/CD8+. Moreover, qualitative specific 
immune response test evaluated T lymphocyte 
function in order to assess the ability to produce 
IL-2 and TNF-a after PHA stimulation.  
Analysis of Lymphocyte Surface Markers
It used 50 mL fresh heparinized blood. The 
principle is evaluate the positive result after 
adding CD45+ (to differentiate lymphocytes 
group), CD3+ (to differentiate B and T 
lymphocyte), CD4+ (to differentiate T helper 
cell), and CD8+ (to differentiate T cytotoxic cell) 
markers. T helper cell is CD45+/CD3+/CD4+ 
and T cytotoxic cell is  CD45+/CD3+/CD8+. 
The measurement of positive result was using 
flow cytometry BD FACS CaliburTM .
Analysis of T Cell Activation Markers
The function of T lymphocyte was evaluated 
by measuring the expression of IL-2 and 
TNF-a on the unstimulated CD4+ and CD8+ T 
lymphocyte before and after PHA stimulation. 
The lymphocyte was stimulated for 4-6 hours 
followed by FITC IL-2 and FITC TNF-a 
specific staining (BD Biosciences). The flow 
cytometry BD FACS CaliburTM will calculate 
the proportion of IL-2 and TNF-a expression 
that produce by T lymphocyte.
Analysis of Neutrophil Phagocytosis
The Neutrophil Phagocytosis examination 
was measured using Phagotest kit (Glycotope 
Biotechnology). This test will count the 
percentage of phagocyte actively eliminate 
the bacteria. The examination is consisting of 
dispensing, activation, incubation, quenching, 
washing, lysing and fixation, washing, DNA 
staining and reading. The neutrophil count 
used 10000-15000 cells per sample. Then the 
percentage of bacteria contained neutrophil 
labelled by fluorescence and counted using flow 
cytometry BD FACS CaliburTM. Neutrophil was 
identified as high side light scatter (SSC-H) and 
large forward light scatter (FSC-H) distribution. 
Statistical Analysis
Analysis of the data was done using 
Statistical Package for Social Sciences (SPSS) 
version 20.0. The categoric variable consisted of 
sex, type of thalassaemia, nutrition status, type 
of blood transfusion, frequency of transfusion, 
iron chelation and hepatitis status. The numeric 
variables were age, anemia degree, neutrophil 
count and phagocytosis, total lymphocyte 
count,  T lymphocyte count, CD4+/CD8+ ratio, 
activated T lymphocyte with IL-2 and TNF-α 
markers, ferritin, and transferin saturation. The 
immune response parameter was analysed by 
paired t-test for the normal distribution and 
wilcoxon signed ranks for the not normal one.
RESULTS
From 67 post-splenectomy medical records, 
only 58 subjects were eligible (6 subjects 
declined, 2 subjects were still under tuberculosis 
treatment and 1 subject was unable to be 
contacted). The 58 non-splenectomy thalassemia 
subjects were matched by age and sex with post-
splenectomy thalassemia subjects. Twenty-two 
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out of 58 (37.9%) non-splenectomy subjects 
were on hypersplenism status. The median age 
was 21 years old (range 12-38 years) and more 
than half of the subjects were female (68 subjects, 
58.6%). (Table 1)
The most common type of thalassemia 
during this study were b and b-HbE on both 
groups. Almost half of the subjects (45.7%) 
had good nutritional status followed by 
underweight (37.1%), severe malnourished 
(14.7%), overweight (1.7%) and obesity 
(0.8%). Although nutritional status were equally 
distributed between both groups (p=0.086), 
the mean calorie intake of post-splenectomy 
group (1,943.29 (SD 334.43) kcal) were lower 
than non-splenectomy group (2,102.45 (SD 
388.85) kcal) (p=0.019). Therefore, calorie 
intake and nutritional status had moderate 
correlation on both, post-splenectomy and 
non-splenectomy (r=0.421, p<0.001), (r=0.561, 
p<0.001), respectively.
Eight out of 58 post-splenectomy subjects had 
less than 4 times per year transfusion compared 
to non-splenectomy groups who had more 
frequent transfusion (p=0.014). Therefore, it was 
no significant difference on mean haemoglobin 
level between post-splenectomy (7.50 (SD 0.87) 
g/dL) and non-splenectomy (7.22 (SD 0.87) g/dL) 
(p=0.088). Blood transfusion frequency within a 
year on post-splenectomy groups had median 8 (0 
to 24) times compared to non-splenectomy groups 
with median 12 (6 to 36) times (p=0.005). Post-
splenectomy groups used more washed PRC than 
non-splenectomy. Moreover, severe iron overload 
was found on post-splenectomy group that showed 
by higher ferritin and transferrin saturation 
significantly compared to non-splenectomy group. 
In addition, deferiprone is the most common iron 
chelation therapy on both groups.
Hepatitis is an important infection that can 
affect the immune response parameter. The total 
subjects who were positively infected by hepatitis 
B or C was similar between both groups (p>0.05). 
Respiratory infection was the most common 
mild infection found on post-splenectomy and 
non-splenectomy groups within a year. The 
median of mild infection episodes within one 
year on post-splenectomy groups were 2.02 (0 
to 12) times with duration of 4.5 (0 to 60) days 
whilst non-splenectomy groups was 0.81 (0 to 8) 
times with duration 0 (0 to 100) days, (p=0.004, 
p=0.001 respectively). Severe infections on post-
splenectomy group were sepsis for 2 weeks and 
diarrhea for 1 weeks whereas on non-splenectomy 
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was typhoid fever for 4 days. Eventually, post-
splenectomy groups were often infected with 
longer duration of infection.
Thalassemia Major Non-specific Immune 
Response
Neutrophil count on post-splenectomy had 
median 8,846 (2,720 to 67,150) sel/µL whereas 
non-splenectomy had 3,211 (1,130 to 7,360) 
sel/µL (p<0.001). Neutrophil phagocytosis of 
post-splenectomy group had median 29.79 (4 to 
81) percent whilst non-splenectomy group had 
55.83 (2 to 133) percent (p<0.001). Therefore, 
the ability of neutrophil phagocytosis on post-
splenectomy group was significantly lower 
than non-splenectomy group. Hypersplenism 
is one of indication to perform splenectomy 
on thalassemia patients. The differences of 
neutrophil phagocytosis between hypersplenism 
and non-hypersplenism of non-splenectomy 
group are shown in Figure 1. and CD8+ was also significantly accelerated. 
Therefore, CD4+/CD8+ ratio was stable. There 
were no differences from all immune response 
parameter among non-splenectomy group with 
and without hipersplenism. 
The production of IL-2 and TNF-α was used 
in order to measure function of T lymphocyte 
activation. Table 3 showed there were no 
differences on T lymphocyte CD4+ and CD8+ 
cytokine production (IL-2 and TNF-α) between 
both groups.
DISCUSSION
Thalassemia major patients in Indonesia 
































Figure 1. Neutrophil phagocytosis function differences among 
non-splenectomy group with and without hypersplenism
Thalassemia Major Specific Immune 
Response
The quantitative tests for thalassemia 
major specific immune response were higher 
in all parameters on post-splenectomy group 
compared to non-splenectomy group. Most of 
the parameters except CD4+/CD8+ ratio showed 
significant differences. The total lymphocyte 
count and total T lymphocyte count was 
significantly increased on post-splenectomy 
group, as a consequence, the T lymphocyte CD4+ 
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*Wilcoxon Signed Ranks test, # median (range)
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blood transfusion and inadequate use of iron 
chelation. The blood transfusion was improperly 
scheduled due to financial constrainst for visiting 
the hospital. Besides, these patients showed 
low compliance on iron chelating resulted in 
severe iron overload. Moreover, splenectomized 
thalassemia major patients usually has history 
of hypersplenism and varied indication of 
splenectomy. The other limitation of this study 
was improper documentation of infection 
episodes on medical record and insufficient total 
subject for neutrophil phagocytosis examination.
More than half of subjects were b-HbE 
thalassemia (51.7%) followed by b-thalassemia 
(47.4%) and a-thalassemia (0.9%). These might 
be due to the place of study was a refferal hospital 
and located at Java. The patients who visited 
Thalassaemia Center, Cipto Mangunkusumo 
Hospital comes from Jakarta and surrounding 
area. According to Lanni20, b-thalassemia trait 
was 3.2% and HbE thalassemia trait was 4.8% 
in Java island. Moreover, Eijkman Molecular 
Biology Institute reported that a-thalassemia 
comes from Chinese (69%) and Javanese (31%) 
ethnic.21 Eventually, the place of thalassemia 
center and ethnicity surrounding the center will 
influence variety of thalassemia type. 
In this study, good nutritional status was 
more common on non-splenectomy group. On 
the other hand, severe malnourished was more 
common on post-splenectomy group. These were 
due to less calorie intake on post-splenectomy 
group. It is supported by moderate correlation 
and significant result between nutritional status 
and calorie intake on both group of thalassemia 
major. Severe malnourished was more common 
on post-splenectomy group because this group 
had lesser blood transfusion compared to 
non-splenectomy group. Fung et al.22 reported 
the relationship between nutritional status 
with hemoglobin level and blood transfusion 
frequency. Subjects who received routine blood 
transfusion has higher body fat mass and body fat 
percentage compared to subjects who received 
less blood transfusion. Fung et al22, also stated 
that hemoglobin level has positive correlation 
with lean mass (p=0.001). Additionally, the body 
weight of thalassemia major patient might not 
be the actual body weight since the presence 
of spleen enlargement. Therefore, upper arm 
circumference should be used instead of body 
weight on thalassemia major children patients. 
Beside upper arm circumference, calliper 
could be an option in order to measure muscle 
thickness for the adult thalassemia major patient. 
Moreover, it is important to consider body fat 
in thalassemia major patients since adequate 
body fat was needed for optimal growth.22 In 
relation of blood transfusion type, most of post-
splenectomy subjects received washed PRC due 
to incompatibility history.
In this study, subject with positive hepatitis 
B and C was distributed equally on both 
groups (p>0.05). These markers are important 
for thalassemia immune response evaluation 
as hepatitis can lead to liver damage which 
correlated to immune abnormality.23 Monitoring 
and good management such as Hepatitis B 
immunization were needed to prevent liver 
damage.
Previous study reported that main predictor 
for infection in thalassemia major was duration 
of thalassemia since the patient diagnosed, 
frequency of blood transfusion, splenectomy and 
iron chelation.24 It is similar with this study that 
episode of infection was more common on post-
splenectomy than non-splenectomy subjects. The 
higher ferritin level found on post-splenectomy 
subjects affected immune response, which 
resulted in higher susceptible to infection. Spleen 
is an important source of immunocompetent 
lymphocyte.4 Splenectomy and aged more than 
10 years are the precipitating factors for severe 
infection on thalassemia major.25
In normal people, the neutrophil phagocytosis 
function is 96.8–99.59%. This study found that 
neutrophil phagocytosis on thalassemia major 
patients was lower compared to normal. It 
decreased further after splenectomy (29.79%). 
Other study reported there was no difference of 
neutrophil phagocytosis in thalassemia compared 
to normal subjects.16 We found distruption on 
neutrophil phagocytosis in thalassemia major 
especially post-splenectomy subjects. These 
conditions might be due to research methodology 
differences. The lower innate imunity on 
thalassemia major might be correlated to higher 
level of iron overlod as reported by Cantinieaux 
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Iron overload indicated by ferritin and 
transferrin saturation was higher on post-
splenectomy group than non-splenectomy group. 
This condition was due to post-splenectomy 
patients rarely visiting the hospital to get iron 
chelation. Thus, it will affect the immune system 
of post-splenectomy subjects. In this study, 
there were differences on total lymphocyte 
count, total T lymphocyte, CD4+ and CD8+ 
T lymphocyte between post-splenectomy and 
non-splenectomy groups (p<0.001). These 
results were similar to the previous study and 
correlated to amount of blood transfusion and 
ferritin level.1,12,14,27 Iron is important to regulate 
marker expression in surface T lymphocyte and 
expansion of T lymphocyte subsets in vivo and in 
vitro.23,28 In addition, iron chelation has a greater 
effect for influencing thalassemia patients’s 
immune response.13 Deferiprone was the most 
common chelation that used (55.2%) since it is 
the cheapest oral iron chelation in the world29, 
including Indonesia.
Increased T lymphocyte count on post-
splenectomy might be associated with antigen 
could not effectively filtered by spleen. This 
suggests that spleen could play some part in the 
regulation of lymphocyte counts and act as a 
reservoir for lymphocytes produced in the body.27 
Moreover, CD4+ and CD8+ T lymphocyte were 
higher on post-splenectomy groups compared 
to non-splenectomy and control group in the 
previous study.27 These conditions showed an 
activated immune response although it is not 
visible clinically. The CD4+/CD8+ ratio showed 
no significant differences on both groups. 
However, the CD4+/CD8+ ratio is lower than the 
control group in the previous study.27 Reduced 
CD4+/CD8+ ratio is associated to the amount of 
blood transfusion and has negative correlation 
with ferritin level.1
Meanwhile, there were no differences on 
proportion of activated lymphocyte producing 
cytokine (IL-2 and TNF-α) on both groups. 
It was proved that the ability of CD4+ and 
CD8+ T lymphocyte in producing cytokine 
was not affected even after splenectomy. 
Until now, we could not find any study that 
measured proportion of lymphocyte in producing 
cytokine after  mitogen exposure. Interleukin-2 
(IL-2) is the most important cytokine in 
activation and proliferation of T lymphocyte 
especially T reg.30,31 Gharagozloo et al27, showed 
decreased IFN-γ and IL-2 on thalassemia 
as a result of immunosupression due to iron 
overload. Whilst, enhancement of TNF-α on 
post-splenectomy thalassemia major subjects 
was a result of poor antigen filtration which 
resulted in enhanced inflammatory. Moreover, 
T lymphocytes express activated phenotype in 
multitransfused thalassemia major patients. In 
contrast, T-cell proliferation and effector function 
are significantly suppressed.27 These conditions 
are due to increased immune activation and 
constant T-cell turnover could generate the 
premature aging of the immune system and 
immune resources exhaustion.27
Multitransfusion leads to a functional 
status of partial immunodeficiency, which, 
nevertheless seems to have no substantial clinical 
relevance.32 Blood transfusion and activation 
of chronic immune might induce the T reg cell 
which suppresses the T cell effector functions. 
The association between expression marker of 
activated T lymphocyte and multitransfusion was 
indicated that chronic immunologic stimulation is 
presence. Contaminating leukocyte in PRC might 
be a source of imunization to histocompatibility 
antigen in thalassemia patient. Although the 
absence of donor leukocytes on PRC are 
presented in the major histocompatibility 
complex class I pathway of recipient antigen-
presenting cell (APC), which result in activation 
and expansion of recipient CD8+ T cells specific 
for donor minor histocompatibility antigens.27 
Overall, immune response profile of 
hypersplenism was in between post-splenectomy 
and non-splenectomy. Neutrophil count was 
higher and phagocytosis of hypersplenism 
was lower than non-hypersplenism. Although, 
cellular immunity of hypersplenism had no 
significant changes, clinically hypersplenism 
state was important because non-specific 
immune response were already reduced. On 
the other hand, pancytopenia and massive 
splenomegaly were also important to consider. 
Therefore, this study showed that splenectomy 
need a better preparation and consideration. It is 
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recommended to give higher blood transfusion 
volume and effective iron chelation for several 
months in order to reduced hypersplenism state. 
CONCLUSION
There were significant differences on immune 
responses among post-splenectomy and non-
splenectomy groups. The differences were on 
non-specific (neutrophil count and phagocytosis) 
and quantitative specific immune response 
(total lymphocyte count, CD4+ and CD8+ T 
lymphocyte). Splenectomised thalassemia major 
showed a greater degree of susceptibility to 
infections than non-splenectomised thalassemia 
major. Improvement of immune response could 
be achieved by consuming antioxidant vitamin, 
and trace elements (e.g zinc, selenium). They 
provide tissue protection from damaging agents 
such as reactive oxygen through transcription 
factor reaction also cytokine and prostaglandin 
protection. Furthermore, vitamin and trace 
elements boost the improvement of immune 
response through Th1 and inhibit the conversion 
of Th1 into Th2.
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